PharmaLundensis AB (XSAT:PHAL) Quality Rank

View and export this data going back to 2010. Start your Free Trial

What is PharmaLundensis AB Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

PharmaLundensis AB Quality Rank Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB (XSAT:PHAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Medicon Village, Scheelevagen 2, Lund, SWE, 22381

Website

http://www.pharmalundensis.se

PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.